-
April 6, 2019
EMA released the guideline on the non-clinical requirements for radiopharmaceuticals
The European Medicine Agency (EMA) has issued the guideline on the non-clinical requirements for the radiopharmaceuticals. The…
Read More -
April 4, 2019
Import and Release of US-Labelled Choletec (Mebrofenin)
Choletec Canadian product has been unavailable in Canada and US labeled supply was allowed in by Health Canada to bridge in October 2018. Currently, the product is backordered due to logistical…
Read More -
January 21, 2019
Cessation of Mo-99 Production Activities by NTP Radioisotopes Ltd. (NTP) Update ANSTO Press Release – OPAL reactor – Update
The AIPES Security of Supply working Group (SoS WG) composed of Mo-99 processors, research reactors…
Read More -
October 22, 2018
Import and Release of US-Labelled Choletec (Mebrofenin)
Recently, Health Canada received a proposal from Bracco Imaging Canada to import and release US-labelled Choletec (Mebrofenin) into Canada in order to mitigate a shortage…
Read More -
February 2, 2018
Update on Global Medical Isotope Supply — Mise à jour du 2 févrrier au sujet de l’offre internationale d’isotopes médicaux
Dear MSWG members and other stakeholders, This is a follow up to the January 26, 2018 message on the current global supply…
Read More -
January 12, 2018
Update on NTP in South Africa — Mise à jour du 12 janvier au sujet du réacteur NTP en Afrique du Sud
Dear MSWG members and other stakeholders, This is a follow up to the January 12, 2018 message on the NTP reactor status…
Read More